Cargando…

Remote Monitoring in the Home Validates Clinical Gait Measures for Multiple Sclerosis

Background: The timed 25-foot walk (T25FW) is widely used as a clinic performance measure, but has yet to be directly validated against gait speed in the home environment. Objectives: To develop an accurate method for remote assessment of walking speed and to test how predictive the clinic T25FW is...

Descripción completa

Detalles Bibliográficos
Autores principales: Supratak, Akara, Datta, Gourab, Gafson, Arie R., Nicholas, Richard, Guo, Yike, Matthews, Paul M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053510/
https://www.ncbi.nlm.nih.gov/pubmed/30057565
http://dx.doi.org/10.3389/fneur.2018.00561
_version_ 1783340838216007680
author Supratak, Akara
Datta, Gourab
Gafson, Arie R.
Nicholas, Richard
Guo, Yike
Matthews, Paul M.
author_facet Supratak, Akara
Datta, Gourab
Gafson, Arie R.
Nicholas, Richard
Guo, Yike
Matthews, Paul M.
author_sort Supratak, Akara
collection PubMed
description Background: The timed 25-foot walk (T25FW) is widely used as a clinic performance measure, but has yet to be directly validated against gait speed in the home environment. Objectives: To develop an accurate method for remote assessment of walking speed and to test how predictive the clinic T25FW is for real-life walking. Methods: An AX3-Axivity tri-axial accelerometer was positioned on 32 MS patients (Expanded Disability Status Scale [EDSS] 0–6) in the clinic, who subsequently wore it at home for up to 7 days. Gait speed was calculated from these data using both a model developed with healthy volunteers and individually personalized models generated from a machine learning algorithm. Results: The healthy volunteer model predicted gait speed poorly for more disabled people with MS. However, the accuracy of individually personalized models was high regardless of disability (R-value = 0.98, p-value = 1.85 × 10(−22)). With the latter, we confirmed that the clinic T25FW is strongly predictive of the maximum sustained gait speed in the home environment (R-value = 0.89, p-value = 4.34 × 10(−8)). Conclusion: Remote gait monitoring with individually personalized models is accurate for patients with MS. Using these models, we have directly validated the clinical meaningfulness (i.e., predictiveness) of the clinic T25FW for the first time.
format Online
Article
Text
id pubmed-6053510
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-60535102018-07-27 Remote Monitoring in the Home Validates Clinical Gait Measures for Multiple Sclerosis Supratak, Akara Datta, Gourab Gafson, Arie R. Nicholas, Richard Guo, Yike Matthews, Paul M. Front Neurol Neurology Background: The timed 25-foot walk (T25FW) is widely used as a clinic performance measure, but has yet to be directly validated against gait speed in the home environment. Objectives: To develop an accurate method for remote assessment of walking speed and to test how predictive the clinic T25FW is for real-life walking. Methods: An AX3-Axivity tri-axial accelerometer was positioned on 32 MS patients (Expanded Disability Status Scale [EDSS] 0–6) in the clinic, who subsequently wore it at home for up to 7 days. Gait speed was calculated from these data using both a model developed with healthy volunteers and individually personalized models generated from a machine learning algorithm. Results: The healthy volunteer model predicted gait speed poorly for more disabled people with MS. However, the accuracy of individually personalized models was high regardless of disability (R-value = 0.98, p-value = 1.85 × 10(−22)). With the latter, we confirmed that the clinic T25FW is strongly predictive of the maximum sustained gait speed in the home environment (R-value = 0.89, p-value = 4.34 × 10(−8)). Conclusion: Remote gait monitoring with individually personalized models is accurate for patients with MS. Using these models, we have directly validated the clinical meaningfulness (i.e., predictiveness) of the clinic T25FW for the first time. Frontiers Media S.A. 2018-07-13 /pmc/articles/PMC6053510/ /pubmed/30057565 http://dx.doi.org/10.3389/fneur.2018.00561 Text en Copyright © 2018 Supratak, Datta, Gafson, Nicholas, Guo and Matthews. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Supratak, Akara
Datta, Gourab
Gafson, Arie R.
Nicholas, Richard
Guo, Yike
Matthews, Paul M.
Remote Monitoring in the Home Validates Clinical Gait Measures for Multiple Sclerosis
title Remote Monitoring in the Home Validates Clinical Gait Measures for Multiple Sclerosis
title_full Remote Monitoring in the Home Validates Clinical Gait Measures for Multiple Sclerosis
title_fullStr Remote Monitoring in the Home Validates Clinical Gait Measures for Multiple Sclerosis
title_full_unstemmed Remote Monitoring in the Home Validates Clinical Gait Measures for Multiple Sclerosis
title_short Remote Monitoring in the Home Validates Clinical Gait Measures for Multiple Sclerosis
title_sort remote monitoring in the home validates clinical gait measures for multiple sclerosis
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053510/
https://www.ncbi.nlm.nih.gov/pubmed/30057565
http://dx.doi.org/10.3389/fneur.2018.00561
work_keys_str_mv AT supratakakara remotemonitoringinthehomevalidatesclinicalgaitmeasuresformultiplesclerosis
AT dattagourab remotemonitoringinthehomevalidatesclinicalgaitmeasuresformultiplesclerosis
AT gafsonarier remotemonitoringinthehomevalidatesclinicalgaitmeasuresformultiplesclerosis
AT nicholasrichard remotemonitoringinthehomevalidatesclinicalgaitmeasuresformultiplesclerosis
AT guoyike remotemonitoringinthehomevalidatesclinicalgaitmeasuresformultiplesclerosis
AT matthewspaulm remotemonitoringinthehomevalidatesclinicalgaitmeasuresformultiplesclerosis